LivaNova is a medical devices company that designs, develops, and markets advanced devices and therapies through two main business segments: Cardiopulmonary, which provides perfusion systems, heater-cooler devices, and heart-lung machines for cardiac surgery and extracorporeal life support; and Neuromodulation, which develops implantable devices and therapies for patients with movement and neurological disorders, including treatment systems for obstructive sleep apnea. The company serves hospitals, surgeons, and healthcare institutions globally through direct sales and clinical support teams across the United States, Europe, and international markets. LivaNova generates revenue from the sale of medical devices and consumables, with a business model centered on innovation, regulatory compliance, and clinical outcomes expansion across its diversified product portfolio.